| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6823834 | Schizophrenia Research | 2015 | 4 Pages |
Abstract
Our preliminary results provide further support that acute doses of antipsychotic medications bind to the D3R and provide additional support for the further development of this receptor as a treatment target in schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
![Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO](/preview/png/6823834.png "First Page Preview: Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO")
Authors
Ragy R. Girgis, Xiaoyan Xu, Roberto B. Gil, Elizabeth Hackett, Najate Ojeil, Jeffrey A. Lieberman, Mark Slifstein, Anissa Abi-Dargham,